Pyruvate Carboxylase and Pyruvate Dehydrogenase Deficiency

  • Linda De MeirleirEmail author


Pyruvate carboxylase and pyruvate dehydrogenase deficiency are the most common disorders in pyruvate metabolism and almost always affect the central nervous system. The severity and the clinical phenotypes vary, with a range from overwhelming neonatal lactic acidosis and early death to milder presentations. In the differential diagnosis, there are always the respiratory chain defects (see Chap. 22 on mitochondrial disorders).

Diagnosis depends on biochemical analysis in plasma, urine, and CSF followed by enzymatic analysis in various tissues and confirmation by DNA analysis.

Pyruvate carboxylase (PC) deficiency constitutes a defect both in the Krebs cycle and in gluconeogenesis and generally presents with severe neurologic dysfunction and lactic acidosis more frequently than with fasting hypoglycemia. There are three different phenotypes with wide spectrum in severity.

Pyruvate dehydrogenase deficiency (PDH) is most common due to deficiency in the X-linked PDHE1alpha, but also defects in the other subunits of PDH complex have been described. The clinical picture is PDHE1alpha is usually different in boys and girls. Neonatal lactic acidosis and Leigh’s encephalopathy occur more frequently in boys; girls can present with severe seizures and microcephaly. The diagnosis is suspected when lactate and pyruvate are elevated, with a normal pyruvate to lactate ratio.

Further confirmation is done biochemically on fibroblasts, lymphocytes, or muscle, and the different genes can be investigated. A prenatal diagnosis is then possible. Ketogenic diet might help in some patients.


Lactic Acidosis Lipoic Acid Ketogenic Diet Pyruvate Carboxylase Thiamine Pyrophosphate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Further Reading

  1. Barnerias C, Saudubray JM, Touati G et al (2010) Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol 52(2):e1–e9PubMedGoogle Scholar
  2. Brown RM, Head RA, Boubriak II et al (2004) Mutations in the gene for the E1β subunit: a novel cause of pyruvate dehydrogenase deficiency. Hum Genet 115:123–127PubMedCrossRefGoogle Scholar
  3. Brown RM, Head R, Morris AA, Raiman JA et al (2006) Pyruvate dehydrogenase E3 binding protein (protein X) deficiency. Dev med Child Neurol 48:756–760PubMedCrossRefGoogle Scholar
  4. De Meirleir L, Specola N, Seneca S, Lissens W (1998) Pyruvate dehydrogenase E1alpha deficiency in a family: different clinical presentation in two siblings. J Inherit Metab Dis 21:224–226PubMedCrossRefGoogle Scholar
  5. Debray FG, Lambert M, Gagne R et al (2008) Pyruvate dehydrogenase deficiency presenting as intermittent isolated acute ataxia. Neuropediatrics 39:20–23PubMedCrossRefGoogle Scholar
  6. Elpeleg ON, Ruitenbeek W, Jakobs C et al (1995) Congenital lacticacidemia caused by lipoamide dehydrogenase deficiency with favorable outcome. J Pediatr 126:72–74PubMedCrossRefGoogle Scholar
  7. Garcia-Gazorla A, Rabier D, Touati G et al (2006) Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann Neurol 59:121–127CrossRefGoogle Scholar
  8. Grafakou O, Oexle K, van den Heuvel L et al (2003) Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation. Eur J Pediatr 162:714–718PubMedCrossRefGoogle Scholar
  9. Head R, Brown R, Zolkipli Z et al (2005) Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency. Ann Neurol 58:234–241PubMedCrossRefGoogle Scholar
  10. Hong YS, Korman SH, Lee J et al (2003) Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: possible beneficial effect of vitamin therapy. J Inherit Metab Dis 26:816–818PubMedCrossRefGoogle Scholar
  11. Lissens W, De Meirleir L, Seneca S et al (2000) Mutations in the X-linked pyruvate dehydrogenase (E1) α sububit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 15:209–219PubMedCrossRefGoogle Scholar
  12. Maj M, Mackay N, Levandovskyi V et al (2005) Pyruvate dehydrogenase phosphatase deficiency: identification of the first mutation in two brothers and restoration of activity by protein complementation. J Clin Endocrinol Metab 90:4101–4107PubMedCrossRefGoogle Scholar
  13. Michotte A, De Meirleir L, Lissens W et al (1993) Neuropathological findings of a patient with pyruvate dehydrogenase E1 alpha deficiency presenting as a cerebral lactic acidosis. Acta Neuropathol (Berl) 85:674–678CrossRefGoogle Scholar
  14. Monnot S, Serre V, Chadefaux-Vekemans B et al (2009) Structural insights on pathogenic effects of novel mutations causing pyruvate carboxylase deficiency. Hum Mutat 30:734–740PubMedCrossRefGoogle Scholar
  15. Quintana E, Gort L, Busquets C et al (2009) Mutational study in the PDHA1 gene of 40 patients suspected of pyruvate dehydrogenase complex deficiency. Clin Gen 77:274–282Google Scholar
  16. Robinson BH, Taylor J, Sherwood WG (1980) The genetic heterogeneity of lactic acidosis: occurrence of recognizable inborn errors of metabolism in a pediatric population with lactic acidosis. Pediatr Res 14:956–962PubMedCrossRefGoogle Scholar
  17. Robinson BH, Oei J, Sherwood WG et al (1984) The molecular basis for the two different clinical presentations of classical pyruvate carboxylase deficiency. Am J Hum Genet 36:283–294PubMedCentralPubMedGoogle Scholar
  18. Robinson BH, MacKay N, Chun K, Ling M (1996) Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex. J Inherit Metab Dis 19:452–462PubMedCrossRefGoogle Scholar
  19. Saudubray JM, Marsac C, Charpentier C et al (1976) Neonatal congenital lactic acidosis with pyruvate carboxylase deficiency in two siblings. Acta Paediatr Scand 65:717–724PubMedGoogle Scholar
  20. Van Coster RN, Fernhoff PM, De Vivo DC (1991) Pyruvate carboxylase deficiency: a benign variant with normal development. Pediatr Res 30:1–4PubMedCrossRefGoogle Scholar
  21. Willemsen M, Rodenburg RJT, Teszas A et al (2006) Females with PDHA1 gene mutations: a diagnostic challenge. Mitochondrion 6:155–159PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Pediatric NeurologyVZ-BrusselBrusselsBelgium

Personalised recommendations